Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery

NCT01765270 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped The study was stopped due to poor enrollment.

Conditions

Type 2 Diabetes Mellitus
Cardiovascular Disease

Interventions

DRUG: Saxagliptin
DRUG: Placebo

Sponsor

Duke University